Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Experimental Conditions That Enhance Potency of an Antibacterial Oligo-Acyl-Lysyl

Yair Goldfeder, Fadia Zaknoon, Amram Mor
Yair Goldfeder
Department of Biotechnology & Food Engineering, Technion-Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fadia Zaknoon
Department of Biotechnology & Food Engineering, Technion-Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amram Mor
Department of Biotechnology & Food Engineering, Technion-Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: amor@tx.technion.ac.il
DOI: 10.1128/AAC.01656-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Oligo-acyl-lysyls (OAKs) are synthetic mimics of host defense peptides known to exert antibacterial activity both in cultures and in animal models of disease. Here, we investigated how environmental conditions (temperature, pH, and ionic strength) affect the antibacterial properties of an octamer derivative, C12K-7α8. Data obtained with representative bacteria, including the Gram-negative bacterium Escherichia coli and the Gram-positive bacteria Listeria monocytogenes and Staphylococcus aureus, showed that OAK's potency was proportionally affected by pH changes and subsided essentially throughout a wide range of salt concentrations and temperature values, whereas antistaphyloccocal activity was relatively more vulnerable. It was rather the mode of action that was most susceptible to the environmental changes. Thus, OAK's bactericidal effect was limited to a growth-inhibitory effect under acidic pH, low temperatures, or high salt concentrations, whereas basic pH or high temperatures have enhanced the bactericidal kinetics. Properties of binding to model phospholipid membranes provided evidence that correlated the differential modes of action with variable binding affinities. Interestingly, combination of the optimal incubation conditions resulted in a remarkable increase in potency, as expressed by a 16- to 32-fold reduction in the MIC value and by much faster bactericidal rates (>99% death induced within minutes versus hours) compared with the standard incubation conditions. Collectively, the data suggest that OAKs might be useful in developing design strategies for robust antimicrobial peptides that are able to affect a pathogen's viability under a large spectrum of incubation conditions.

Host defense peptides (HDPs) are ever-present components of the innate immune system across all organisms (25, 60). These molecules have been widely studied for their vast range of activities, such as antimicrobial, antitumor, mitogenic, and chemical signaling properties (7, 22, 42, 59). Nevertheless, a number of disadvantages, including toxicity, poor bioavailability, and/or high production costs, continue to compromise their potential uses, especially as systemic drugs (6, 22). Also, despite the fact that these compounds have been investigated for over 2 decades, their mechanism of action is not fully understood. Namely, many HDPs are believed to exert antibacterial activity by disrupting the integrity of the cell wall and/or the plasma membrane (16, 25, 54), whereas others were proposed to hamper intracellular functions (4, 48). While, this nonspecific multitarget mode of action seems likely to significantly prevent the emergence of resistance (36, 59) and indeed significantly accounts for both scientific and applicative widespread interests in these peptides, new innovative tools are needed to shed light onto fine mechanistic details of this complex antimicrobial system.

Various synthetic mimics using a small number of building blocks are able to capture the essential antimicrobial properties of HDPs while overcoming some of their shortcomings (35, 43, 51). Several promising approaches were proposed using a variety of peptide-like or pseudopeptide oligomers, including β-peptides (34, 52), peptoids (9, 53), arylamides (55), and phenylene ethynylenes (8), to name a few examples. Oligo-acyl-lysyls (OAKs) represent one of the simpler approaches for HDP mimicry. OAKs typically consist of alternating acyl chains and the cationic amino acid lysine (recently reviewed in reference 43). Various OAK sequences were shown to affect viability of a wide spectrum of bacterial species (30, 38, 44, 49), while others displayed antiparasite (33, 37) or antitumor (26) activities. In each case, structure-activity relationship (SAR) studies have highlighted two major characteristics: selective cytotoxicity became apparent upon achievement of an optimal hydrophobicity and charge window (30, 38, 39), whereas poor performances of some of these lipopeptide-like compounds were often linked to the tendency of hydrophobic sequences to aggregate in solution (38, 50).

Some antibacterial aspects of the OAK sequence C12K-7α8 (the molecular structure is shown in Fig. 1) were addressed in previous studies (15, 31, 39, 44). This OAK was preferentially active against Gram-negative bacteria both in vitro and in vivo (31, 39, 44), suggesting a potential interest in therapeutic use and therefore worthy of better understanding its antibacterial properties. Previous mechanistic studies have shown that C12K-7α8 exerted a bactericidal effect by breaching the bacterial permeability barrier, as evidenced by abrupt depolarization of the cytoplasmic membrane, immediately followed by the leakage of intracellular solutes (44). The use of surface plasmon resonance (SPR) technology for binding analysis provided strong support to this mechanism, indicating that the OAK selectively binds and reorganizes by insertion within model phospholipid membranes mimicking the cytoplasmic membrane of Gram-negative bacteria (39, 44). Further support was provided by additional studies demonstrating its ability to interact with anionic lipids, induce lateral phase separation, and promote the segregation of anionic and zwitterionic lipids (15). Here, to investigate new means for improving potency of C12K-7α8, we assessed the effects of various environmental conditions such as ionic strength, pH, and temperature on various properties, including antibacterial potency, binding properties, and organization in solution.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Molecular structure of the studied OAK, C12K-7α8. The N terminus is dodecanoyl-lysyl (C12K). Parentheses define an α8 (aminooctanoyl-lysyl) subunit.

MATERIALS AND METHODS

Synthesis and purification.The OAK was synthesized by the solid-phase method using 9-fluorenylmethyloxycarbonyl active ester chemistry (17) using a 433A peptide synthesizer (Applied Biosystems), as reported previously (39). After cleavage from the resin, the crude OAKs were purified to >95% chromatographic homogeneity by reverse-phase high-pressure liquid chromatography (Alliance-Waters). Product identity was confirmed by subjecting the purified OAKs to electrospray mass spectrometry (ZQ-Waters). OAKs were stored as a lyophilized powder at −20°C. Prior to experimentation, fresh solutions were prepared in distilled water (1 mg/ml), briefly vortexed, and sonicated, and these were used as stock solutions in all experiments.

Bacteria. Escherichia coli O157:H7 (ATCC 43894) and Staphylococcus aureus (ATCC 25923, ATCC 29213, methicillin-resistant S. aureus [MRSA] ATCC 43300, and MRSA clinical isolate 15903) cells were grown overnight in LB medium (85 mM NaCl, 0.5% yeast extract, 1% tryptone, pH 7) and Listeria monocytogenes Li2 (ATCC 19115) cells were grown on Bacto brain heart infusion (BHI) medium (Difco Labs, France) (also containing 85 mM NaCl at pH 7), diluted to 2 × 107 to 4 × 107 CFU/ml, and incubated at room temperature for 60 min prior to being assayed. The stock cultures (of all strains) were maintained in 50:50 glycerol-LB broth at −80°C.

Antibacterial assays.Unless otherwise stated, antibacterial activities were evaluated by comparing the MIC, determined using the microdilution assay in sterilized 96-well plates in a final volume of 200 μl as follows. A stock solution of the OAK was diluted 10-fold in culture medium. One hundred microliters of medium containing bacteria (2 to 4 × 105 cells/ml) was added to 100 μl of medium containing OAK (serial 2-fold dilutions). Growth under standard conditions (medium containing 85 mM NaCl, pH 7, at 37°C) was determined by optical density measurements at 620 nm. The MIC was considered the lowest peptide concentration that showed no increase in optical density after 24 h of incubation (72 h in the 4°C assay). Alternatively, to determine the MIC under nonstandard conditions, bacteria and OAK were preconditioned for 15 min prior to passing to the specified incubation conditions. Results were routinely obtained from at least two independent assays performed in duplicates, whereas data points displaying a 2-fold difference in Table 1 were submitted to a second round of additional experiments to verify statistical significance.

View this table:
  • View inline
  • View popup
TABLE 1.

Effects of incubation conditions on potency of C12K-7α8

To determine the bactericidal kinetics under standard conditions, the assay was performed in test tubes in a final volume of 1 ml. One hundred microliters of bacterial suspension was added to 900 μl of medium containing no OAK or various OAK concentrations. After exposure to peptide at 37°C (up to 240 min), cultures were subjected to serial 10-fold dilutions (up to 1/106) by adding 20 μl of sample to 180 μl saline (140 mM NaCl). Cell counts were determined using the drop plate method (three 20-μl drops onto LB or BHI agar plates). CFU were counted after 16 to 24 h of incubation at 37°C. To assess the effect of temperature variations, the assays were performed as described above but bacteria and test tubes containing the culture medium were first incubated for 15 min at the specified temperatures (i.e., 4, 25, and 48°C). For pH and salt variations, the culture medium was brought to the desired pH by adding NaOH or HCl (1 N) or to the desired saline concentration by adding NaCl. Results are expressed as mean CFU ± standard deviations (SD) obtained from two independent experiments performed in duplicates. A result of zero CFU indicates negative cultures.

Binding assays.OAK binding to phospholipidic membranes was determined using an optical biosensor system (BIAcore 2000, Uppsala, Sweden) based on the principles of surface plasmon resonance. The sensor chip L1 (a carboxymethyldextran hydrogel derivatized with lipophilic alkyl chain anchors) was used to prepare a lipid bilayer as described previously (19). To prepare model membranes for the binding studies, small unilamellar vesicles composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (PC/PG) (3:1 molar ratio) were prepared by the sonication method (according to instructions from Avanti Polar) in the buffer corresponding to the incubation conditions used in the antimicrobial assays. The vesicles had a mean diameter of 20 nm, as determined by dynamic light scattering. The liposome solution was used as a stock solution for the surface plasmon resonance (SPR) experiments. The binding assay and analysis were performed as described previously (19), by injecting peptide solutions in phosphate-buffered saline (PBS) at five different concentrations (2-fold dilutions from 50 to 3 μM) in duplicates at a flow rate of 5 ml/min at 25°C. PBS variants in pH and salt concentration were also tested.

Organization in solution.The OAKs’ self-assembly in solution was assessed by light-scattering measurements, using a Jobin-Yvon Horiba Fluorolog-3 system with FluorEssence. Briefly, serial 2-fold dilutions of the OAKs were prepared in PBS starting at a 100 μM concentration and then incubated for 2 h at room temperature. The light scattering of each dilution was measured by holding both the excitation and the emission at 400 nm (slit width, 1 nm). To describe the dependence of the scattered signal on the OAK concentration, the intensity of scattered light was plotted against the total OAK concentrations. Since the light-scattering signal is proportional to the number of aggregated molecules and the size of the aggregate, the slope is indicative of the aggregation tendency and reveals the aggregation properties, and a slope value above unity indicates the presence of an aggregative form.

RESULTS

Effects of pH, salt, and temperature on MIC value.Table 1 summarizes the MIC values obtained under the different incubation conditions tested, as assessed against three pathogenic bacterial species: the Gram-negative bacterium Escherichia coli O157:H7 and the Gram-positive bacteria Listeria monocytogenes Li2 and Staphylococcus aureus (MRSA 15903). Namely, the data obtained with E. coli showed that OAK's activity was significantly reduced (MIC of >50 μM) at extremely acidic conditions (pH ≤ 3.5); activity was recovered at higher acidic pH values and eventually even slightly improved at alkaline pH. Extremely high salt concentrations have somewhat reduced OAK's potency (e.g., by up to 4-fold at 1,030 mM NaCl), but a lower high-salt concentration had negligible effects. In contrast, MgCl2 was more deleterious to OAK's inhibitory activity. Interestingly, the MIC values were hardly affected over a wide range of temperatures in which a 2-fold fluctuation (at most) was obtained between 4°C and 48°C.

Table 1 also shows an essentially similar outcome when activity was assessed against the Gram-positive bacterium L. monocytogenes, although a few differences were noted with S. aureus (MRSA 15903). Thus, basic pH and high temperature exerted a significantly higher potentiating effect, whereas conversely, high NaCl levels more readily reduced OAK's potency. Essentially similar results were observed with 3 additional S. aureus strains (MRSA 43300, 25923, and 29213, for which MIC values under standard conditions were 25, 50, and 50 μM, respectively), although MIC values were not determined for low temperatures as bacteria did not grow in the untreated control experiments (data not shown).

Effects of pH, salt, and temperature on bactericidal kinetics.The effects of the different incubation conditions on the rate of bacterial viability were assessed after exposure to a single concentration (12 μM) of C12K-7α8, a concentration representing the MIC value against S. aureus but 4 and 8 multiples of the respective MIC values against E. coli and Listeria. Figure 2 shows the time-kill curves obtained for each variation. The upper panels of Fig. 2 show the time-kill curves obtained upon pH variations. Although extremely acidic pH conditions (pH 3.5) have reduced bacterial growth even in the absence of OAK, the data showed that varying the pH from 3.5 to 8.5 has drastically affected OAK's mode of action, which reverted from a growth-inhibitory effect (at pH 3.5) to an increasingly potent bactericidal effect with increasing pH values. The middle panels of Fig. 2 show the time-kill curves obtained in the presence of various NaCl concentrations. Clearly, OAK's bactericidal mode of action was increasingly hampered with increasing NaCl levels. The lower panels of Fig. 2 show that low temperatures (4 and 25°C) were associated with an essentially growth-inhibitory effect, whereas bactericidal activity was favored as temperatures increased.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Effects of pH, NaCl, and temperature on OAK's bactericidal kinetics. Bacteria were incubated at the specified conditions in the presence of 12 μM OAK. Plotted are mean CFU values ± standard deviations obtained from two independent experiments performed in duplicates. Standard incubation conditions are highlighted by solid symbols.

Effects of pH and salt on binding properties and organization in solution.The interactions of C12K-7α8 with a model cationic phospholipid membrane were compared using the surface plasmon resonance (SPR) technology. Note that only some of the conditions were assayed because of membrane instability at extreme pH and temperature values. Representative traces of association/dissociation curves are shown in Fig. 3A, demonstrating faster association kinetics upon increasing the pH value from 7 to 8.5. Figure 3B summarizes the binding parameters as analyzed using the two-step binding model (19, 39, 44), demonstrating the increase in the affinity constant (Kapparent) upon increasing pH values (from 5.5 to 8.5) at physiological NaCl concentration (140 mM) and the reduced affinity constant at high salt concentration (pH 7). This correlated well with the outcome from the activity assays, linking OAK's higher potency to its higher propensity to be incorporated within the bilayer at alkaline pH, while the opposite was observed for low pH values or extremely high salt concentrations.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

Effects of pH and ionic strength on membrane-binding properties and OAK's aggregation. (A) SPR trace for a representative run showing the dose-dependent binding curves to a PC/PG (3:1) membrane; (B) apparent affinity constants determined from the SPR traces using the two-step binding model. Changes in pH and salt conditions were assessed at 140 mM NaCl and pH 7, respectively. Error bars represent SD values from independent experiments. The lack of bars indicates reproducibility. (C). Dose dependence of the light-scattering intensities of PBS solutions of C12K-7α8 (square, pH 3.5; circle, pH 8.5; triangle, pH 7.0 at an NaCl concentration of 140 mM; and inverted triangle, pH 7.0 at an NaCl concentration of 1,030 mM) and its analog C12K-7α12 (diamond, pH 7.0 at an NaCl concentration of 140 mM).

To investigate how the extreme incubation conditions might affect OAK's availability in solution, its aggregative state was assessed at the relevant range of concentrations. A hydrophobic analog (C12K-7α12) known to form self-assemblies at low concentrations (38) was used as a positive control. Figure 3C demonstrates that unlike C12K-7α12, C12K-7α8 did not display a detectable aggregation at least up to 50 μM under all conditions used, suggesting that the observed properties were not biased by self-assembly phenomena. In this respect, previous studies have shown that C12K-7α8 lacks secondary structure at the active concentration range, including in its membrane-bound state (38, 39), whereas self-assemblies of C12K-7α8 (at >100 μM) demonstrated thermostability over a wide range of temperatures (at least between 10 and 60°C) (15).

Effects of combined optimal conditions.OAK was tested under the conditions considered as optimal, specifically, at pH 8.5, a temperature of 48°C, and a minimal salt concentration of 85 mM NaCl. As shown in the upper panels of Fig. 4, the new incubation conditions endowed a 16-fold enhanced potency against E. coli (MIC was reduced from 3.1 to 0.2 μM). Similarly, the MICs against L. monocytogenes and S. aureus were reduced by 32- and 16-fold (i.e., from 1.6 to 0.05 μM and from 12.5 to 0.8 μM, respectively).

FIG. 4.
  • Open in new tab
  • Download powerpoint
FIG. 4.

Effects of OAK treatment on MIC and bactericidal kinetics under standard and optimal conditions. The upper panels show the dose dependence of growth inhibition plots comparing standard (solid symbols) versus optimal (open symbols) conditions. The middle and lower panels compare time-kill curves determined under standard and optimal conditions, respectively, where the open and solid symbols represent the untreated control and OAK treatment, respectively. Plotted are mean values ± SD obtained from two independent experiments performed in duplicates.

This increase in OAK's potency was also reflected in terms of the time-kill curves (Fig. 4, compare the middle and lower panels for standard and optimal conditions, respectively); effective reductions of 99% of the bacterial population were observed within about 15 min instead of 2 h for E. coli and L. monocytogenes and >4 h for staphylococci.

DISCUSSION

The data presented demonstrated how variations of temperature, pH, and ionic strength have affected the antibacterial potency of a representative OAK, C12K-7α8. Low temperature repressed OAK's antibacterial properties, as indicated by the higher MIC values, and led to an atypical bacteriostatic effect. A reduction in antibacterial potency at lower temperatures was also observed with various antimicrobial peptides (11, 32, 47, 58). A possible explanation is related (at least partly) to the changes in bacterial membrane fluidity and its fatty acid profile, which negatively affect the partitioning of the OAK/peptide between membrane and medium. Conversely, therefore, the higher membrane fluidity at high temperatures (56) could underlie our observation of OAK's enhanced potency, as reflected in terms of both the MIC value and the killing rate.

Noteworthy is the finding that high NaCl concentrations have only mildly reduced OAK's potency against both E. coli and L. monocytogenes (2- to 4-fold increases in MIC values at the extremely high concentration of 1,030 mM). The fact that the MIC value against S. aureus was relatively higher is unlikely to be salt related but rather stems from lack of bacterial susceptibility, as supported experimentally, where most other strains tested displayed even higher MIC values (see reference 44 and this study). Conversely, the activity of many HDPs was significantly reduced in the presence of even physiological (140 mM) NaCl concentrations (1, 11, 47, 58). Moreover, we find that high NaCl concentrations have converted OAK's mode of action from bactericidal to bacteriostatic. This effect may be a result of the osmotic stress induced by the environment and the bacterial reaction to this stress. The stress responses may reduce bacterial susceptibility to OAK's action by SOS gene expression and/or membrane modifications (12, 27). Also, the E. coli transmembrane potential reportedly decreases significantly as a stress response to acidic conditions (41); this could lead to a reduced propensity for insertion within the membrane. Evidence for reduced binding affinity was provided in SPR experiments, supporting the view that by shielding the charges, salt might affect OAK's kinetics/mode of action rather than its potency since the MIC values were much less susceptible. This view also draws support from the finding that basic pH enhanced the binding affinity to the model membrane and this correlated well with enhanced bactericidal rates and improved MIC values. It is therefore not surprising that by combining the most favorable conditions, OAK was most potent. The combined optimal incubation conditions represent a situation that is most favorable for OAK's action as the bacterial membrane appears to be in a state which induces fluidity/flexibility, thus allowing more OAK molecules to interact more efficiently with the membrane: hence, the lower MIC values and faster bactericidal kinetics. Note that while numerous studies have assessed the individual effects of pH, salt, and temperature on different HDPs (28, 31, 40, 47, 57, 58), we are unable to compare our results, as no other study has attempted to combine the optimal conditions, to our knowledge.

It is also interesting to note that although previous studies of C12K-7α8 argued for a preferential activity against Gram-negative bacteria (15, 39, 44), OAK nevertheless was quite potent against the Gram-positive species Listeria monocytogenes (even more than against E. coli in some cases). This might be related to the membrane composition and cell wall properties (2). Unlike other Gram-positive bacteria whose membrane is composed of nearly 100% negatively charged phospholipids, Listeria contains a mixture of anionic lipids phosphatidylglycerol (PG) and cardiolipin (CL) and a relatively high abundance of lysyl derivatives, the zwitterionic analogs lysyl-PG and lysyl-CL (15, 18). This composition resembles that of E. coli, which also contain a mixture of zwitterionic and anionic lipids (PE/PG/CL) and therefore might be similarly susceptible to lipid domain segregation by C12K-7α8 as described previously (15). Another remarkable characteristic of Listeria is its similarity to Gram-negative bacteria in terms of peptidoglycan structure. Thus, unlike other Gram-positive bacteria whose N-acetylmuramic acid (MurNAc) contains l-alanine, d-glutamine, and l-lysine, Listeria contains l-alanine, d-glutamic acid, and meso-diaminopimelyl, similarly to E. coli (2). Overall these common properties might contribute at least partly to their similar sensitivity to the OAK. Likewise, future studies might verify how inherent differences (e.g., presence of an external membrane in E. coli or the thicker peptidoglycan in Listeria) would contribute to the observed dissimilarities. It is nevertheless striking how their importance was reduced by altering environmental conditions, thereby enabling OAK to exert a more efficient antibacterial action as well as to cover a wider spectrum of pathogens as observed with S. aureus. These findings are therefore likely to contribute to better understanding the antibacterial effects of OAKs and HDPs and to the design of new treatment strategies, including topical applications for polymicrobial infections such as diabetic foot ulcer (29) or oral mucositis (13).

In addition to their therapeutic potential, HDPs are believed to be useful in a variety of additional applications, such as in cosmetics or food safety (20, 46, 47, 58). The virulent form of E. coli designated serotype O157:H7 has highly efficient mechanisms of global stress resistance, which contribute to its low infectious dose and tolerance to stress factors, including acidic pH (41). Similarly, unlike S. aureus, Listeria monocytogenes can survive across a wide range of environmental conditions such as low pH and temperatures, as well as high salt concentrations, and thereby pose a potential risk to human health (21, 24). In this respect, our data point to potential uses of OAKs in food safety as the antimicrobial properties were studied under incubation conditions relevant to food product preservation.

In conclusion, this study showed that a representative OAK maintained antibacterial activity under a wide range of conditions and might therefore be useful in developing design strategies for antimicrobial compounds that are able to affect the pathogens’ viability under a large spectrum of incubation conditions. With their simpler and robust structure, OAKs might be better suitable for various applications than HDPs.

ACKNOWLEDGMENTS

This research was supported by the Israel Science Foundation (grant 283/08).

FOOTNOTES

    • Received 22 November 2009.
    • Returned for modification 30 December 2009.
    • Accepted 5 April 2010.
  • Copyright © 2010 American Society for Microbiology

REFERENCES

  1. 1.↵
    Abler, L., N. Klapes, B. Sheldon, and T. Klaenhammer. 1995. Inactivation of food-borne pathogens with magainin peptides. J. Food Prot.58:381-388.
    OpenUrl
  2. 2.↵
    Bierne, H., and P. Cossart. 2007. Listeria monocytogenes surface proteins: from genome predictions to function. Microbiol. Mol. Biol. Rev.71:377-397.
    OpenUrlAbstract/FREE Full Text
  3. 3.
    Reference deleted.
  4. 4.↵
    Boman, H. G., B. Agerberth, and A. Boman. 1993. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun.61:2978-2984.
    OpenUrlAbstract/FREE Full Text
  5. 5.
    Reference deleted.
  6. 6.↵
    Bradshaw, J. 2003. Cationic antimicrobial peptides: issues for potential clinical use. BioDrugs17:233-240.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol.3:238-250.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Choi, S., A. Isaacs, D. Clements, D. Liu, H. Kim, R. Scott, J. Winkler, and W. DeGrado. 2009. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc. Natl. Acad. Sci. U. S. A.106:6968.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Chongsiriwatana, N. P., J. A. Patch, A. M. Czyzewski, M. T. Dohm, A. Ivankin, D. Gidalevitz, R. N. Zuckermann, and A. E. Barron. 2008. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. U. S. A.105:2794-2799.
    OpenUrlAbstract/FREE Full Text
  10. 10.
    Reference deleted.
  11. 11.↵
    Cudic, M., B. A. Condie, D. J. Weiner, E. S. Lysenko, Z. Q. Xiang, O. Insug, P. Bulet, and L. Otvos. 2002. Development of novel antibacterial peptides that kill resistant isolates. Peptides23:2071-2083.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Diez-Gonzalez, F., and J. Russell. 1999. Factors affecting the extreme acid resistance of Escherichia coli O157: H7. Food Microbiol.16:367-374.
    OpenUrlCrossRef
  13. 13.↵
    Donnelly, J., L. Bellm, J. Epstein, S. Sonis, and R. Symonds. 2003. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect. Dis.3:405-412.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.
    Reference deleted.
  15. 15.↵
    Epand, R. M., S. Rotem, A. Mor, B. Berno, and R. F. Epand. 2008. Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc.130:14346-14352.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Epand, R. M., and H. J. Vogel. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta1462:11-28.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res.35:161-214.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Fischer, W., and K. Leopold. 1999. Polar lipids of four Listeria species containing L-lysylcardiolipin, a novel lipid structure, and other unique phospholipids. Int. J. Syst. Bacteriol.49:653-662.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Gaidukov, L., A. Fish, and A. Mor. 2003. Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry42:12866-12874.
    OpenUrlCrossRefPubMed
  20. 20.↵
    Galvez, A., H. Abriouel, R. L. Lopez, and O. N. Ben. 2007. Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol.120:51-70.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    Gandhi, M., and M. L. Chikindas. 2007. Listeria: a foodborne pathogen that knows how to survive. Int. J. Food Microbiol.113:1--15.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Gordon, Y., E. Romanowski, and A. McDermott. 2005. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res.30:505-515.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.
    Reference deleted.
  24. 24.↵
    Hamon, M., H. Bierne, and P. Cossart. 2006. Listeria monocytogenes: a multifaceted model. Nat. Rev. Microbiol.4:423-434.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol.24:1551-1557.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Held-Kuznetsov, V., S. Rotem, Y. Assaraf, and A. Mor. 2009. Host-defense peptide mimicry for novel antitumor agents. FASEB J.23:4299-4307.
    OpenUrlCrossRefPubMed
  27. 27.↵
    Humayun, M. Z. 1998. SOS and Mayday: multiple inducible mutagenic pathways in Escherichia coli. Mol. Microbiol.30:905-910.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    Lee, I. H., Y. Cho, and R. I. Lehrer. 1997. Effects of pH and salinity on the antimicrobial properties of clavanins. Infect. Immun.65:2898-2903.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    Lipsky, B., K. Holroyd, and M. Zasloff. 2008. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double blinded, multicenter trial of pexiganan cream. Clin. Infect. Dis.47:1537-1545.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    Livne, L., T. Kovachi, H. Sarig, R. F. Epand, F. Zaknoon, R. M. Epand, and A. Mor. 2009. Design and characterization of a broad-spectrum bactericidal acyl-lysyl oligomer. Chem. Biol.16:1250-1258.
    OpenUrlCrossRefPubMed
  31. 31.↵
    Makobongo, M. O., T. Kovachi, H. Gancz, A. Mor, and D. S. Merrell. 2009. In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori. Antimicrob. Agents Chemother.53:4231-4239.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    Mendoza, F., M. Maqueda, A. Galvez, M. Martinez-Bueno, and E. Valdivia. 1999. Antilisterial activity of peptide AS-48 and study of changes induced in the cell envelope properties of an AS-48-adapted strain of Listeria monocytogenes. Appl. Environ. Microbiol.65:618-625.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    Mor, A. 2009. Multifunctional host defense peptides: antiparasitic activities. FEBS J.276:6474-6482.
    OpenUrlCrossRefPubMed
  34. 34.↵
    Mowery, B. P., S. E. Lee, D. A. Kissounko, R. F. Epand, R. M. Epand, B. Weisblum, S. S. Stahl, and S. H. Gellman. 2007. Mimicry of antimicrobial host-defense peptides by random copolymers. J. Am. Chem. Soc.129:15474-15476.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Mowery, B. P., A. H. Lindner, B. Weisblum, S. S. Stahl, and S. H. Gellman. 2009. Structure-activity relationships among random nylon-3 copolymers that mimic antibacterial host-defense peptides. J. Am. Chem. Soc.131:9735-9745.
    OpenUrlCrossRefPubMed
  36. 36.↵
    Perron, G. G., M. Zasloff, and G. Bell. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci.273:251-256.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    Radzishevsky, I., M. Krugliak, H. Ginsburg, and A. Mor. 2007. Antiplasmodial activity of lauryl-lysine oligomers. Antimicrob. Agents Chemother.51:1753-1759.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    Radzishevsky, I. S., T. Kovachi, Y. Porat, L. Ziserman, F. Zaknoon, D. Danino, and A. Mor. 2008. Structure-activity relationships of antibacterial acyl-lysine oligomers. Chem. Biol.15:354-362.
    OpenUrlCrossRefPubMed
  39. 39.↵
    Radzishevsky, I. S., S. Rotem, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor. 2007. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol.25:657-659.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    Rasch, M. 2002. The influence of temperature, salt and pH on the inhibitory effect of reuterin on Escherichia coli. Int. J. Food Microbiol.72:225-231.
    OpenUrlCrossRefPubMed
  41. 41.↵
    Richard, H., and J. W. Foster. 2004. Escherichia coli glutamate- and arginine-dependent acid resistance systems increase internal pH and reverse transmembrane potential. J. Bacteriol.186:6032-6041.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    Rivas, L., J. Luque-Ortega, and D. Andreu. 2009. Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim. Biophys. Acta1788:1570-1581.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    Rotem, S., and A. Mor. 2009. Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta1788:1582-1592.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    Rotem, S., I. S. Radzishevsky, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor. 2008. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J.22:2652-2661.
    OpenUrlCrossRefPubMed
  45. 45.
    Reference deleted.
  46. 46.↵
    Rydlo, T., J. Miltz, and A. Mor. 2006. Eukaryotic antimicrobial peptides: promises and premises in food safety. J. Food Sci.71:125.
    OpenUrlCrossRef
  47. 47.↵
    Rydlo, T., S. Rotem, and A. Mor. 2006. Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions. Antimicrob. Agents Chemother.50:490-497.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Sahl, H., U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi. 2005. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol.77:466.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    Sarig, H., L. Livne, V. Held-Kuznetsov, F. Zaknoon, A. Ivankin, D. Gidalevitz, and A. Mor. 2009. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. [Epub ahead of print.]
  50. 50.↵
    Sarig, H., S. Rotem, L. Ziserman, D. Danino, and A. Mor. 2008. Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers. Antimicrob. Agents Chemother.52:4308-4314.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    Scott, R., W. DeGrado, and G. Tew. 2008. De novo designed synthetic mimics of antimicrobial peptides. Curr. Opin. Biotechnol.19:620-627.
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    Seebach, D., and J. Gardiner. 2008. Beta-peptidic peptidomimetics. Acc. Chem. Res.41:1366-1375.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    Shah, N. H., G. L. Butterfoss, K. Nguyen, B. Yoo, R. Bonneau, D. L. Rabenstein, and K. Kirshenbaum. 2008. Oligo(N-aryl glycines): a new twist on structured peptoids. J. Am. Chem. Soc.130:16622-16632.
    OpenUrlCrossRefPubMed
  54. 54.↵
    Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers66:236-248.
    OpenUrlCrossRefPubMedWeb of Science
  55. 55.↵
    Tang, H., R. J. Doerksen, T. V. Jones, M. L. Klein, and G. N. Tew. 2006. Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones. Chem. Biol.13:427-435.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    Verheul, A., N. J. Russell, T. H. R. Van, F. M. Rombouts, and T. Abee. 1997. Modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A. Appl. Environ. Microbiol.63:3451-3457.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    Wu, G., J. Ding, H. Li, L. Li, R. Zhao, Z. Shen, X. Fan, and T. Xi. 2008. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332. Curr. Microbiol.57:552-557.
    OpenUrlCrossRefPubMed
  58. 58.↵
    Yaron, S., T. Rydlo, D. Shachar, and A. Mor. 2003. Activity of dermaseptin K4-S4 against foodborne pathogens. Peptides24:1815-1821.
    OpenUrlCrossRefPubMed
  59. 59.↵
    Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev.55:27-55.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature415:389-395.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Experimental Conditions That Enhance Potency of an Antibacterial Oligo-Acyl-Lysyl
Yair Goldfeder, Fadia Zaknoon, Amram Mor
Antimicrobial Agents and Chemotherapy May 2010, 54 (6) 2590-2595; DOI: 10.1128/AAC.01656-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Experimental Conditions That Enhance Potency of an Antibacterial Oligo-Acyl-Lysyl
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Experimental Conditions That Enhance Potency of an Antibacterial Oligo-Acyl-Lysyl
Yair Goldfeder, Fadia Zaknoon, Amram Mor
Antimicrobial Agents and Chemotherapy May 2010, 54 (6) 2590-2595; DOI: 10.1128/AAC.01656-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Oligopeptides

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596